Eligo Bioscience logo

Eligo Bioscience

Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.

10

Funding Rounds

$87.6m

Money raised

Overview

Eligo Bioscience is a developer of novel genetic medicines founded in 2014 by Timothy Lu, Xavier Duportet, Luciano Marraffini and David Bikard.

Funding

Funding series

Funding Series Analysis

The company Eligo Bioscience has raised a total of $57.7m in funding over 10 rounds.

Key Insights:

  • Eligo Bioscience Grant Funding Round, May 2025: $5m
  • Eligo Bioscience December 2023 Series B Funding Round: $30m
  • Eligo Bioscience April 2018 Series A Funding Round: $1.9m
  • Eligo Bioscience September 2017 Series A Funding Round: $18m
  • Eligo Bioscience July 2015 Seed Funding Round: $2.8m
  • Eligo Bioscience funding round, September 2017: $20m
  • Eligo Bioscience Grant (money), January 2019: $4.72m
  • Eligo Bioscience Grant (money), September 2017: $2m
  • Eligo Bioscience Seed round, July 2015: $3.15m
Eligo Bioscience logo
Eligo Bioscience Grant Funding Round, May 2025 $5m
Eligo Bioscience logo
Eligo Bioscience December 2023 Series B Funding Round $30m
Eligo Bioscience logo
Eligo Bioscience April 2018 Series A Funding Round $1.9m
Eligo Bioscience logo
Eligo Bioscience September 2017 Series A Funding Round $18m
Eligo Bioscience logo
Eligo Bioscience July 2015 Seed Funding Round $2.8m
Eligo Bioscience logo
Eligo Bioscience funding round, September 2017 $20m
Eligo Bioscience logo
Eligo Bioscience Grant (money), January 2019 $4.72m
Eligo Bioscience logo
Eligo Bioscience Grant (money), September 2017 $2m
Eligo Bioscience logo
Eligo Bioscience Seed round, July 2015 $3.15m